Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer
SALT LAKE CITY, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the promotion of Nicole Lambert to chief operating officer (COO). In her new role, she will continue to report directly to Paul J. Diaz, president and CEO, Myriad Genetics. Over a 20-year career at the company, Lambert served in several senior leadership positions, most recently overseeing Myriad's Oncology, Women's Health and International business units as well as genetic testing laboratory operations. As COO, she assumes additional responsibility for accelerating the company's transformation and growth plans, elevating products to t
